| Application no. and date | 13164403.1 (espacenet) (Federated) (European Patent Register), 20071130 | | Patent/reg. no. and date | DK/EP 2662091, 20180822 | | Publication date | 20131113 | | Priority no. and date | US 872170 P, 20061201 | | EP pub. no. and date |
EP 2662091 20131113 | | Effective date | | | Applicant/owner | Oklahoma Medical Research Foundation, 825 N.E. 13th Street, Oklahoma City Oklahoma 73104 , US,
Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/157544 | | Inventor | MCEVER, Rodger P., 1716 Guildford Lane
Oklahoma City, OK 73120, US,
Alvarez, Richard, 4817 Clipper Crossing
Edmond, OK 73013, US,
Kawar, Ziad, 2800 NW 46th St.
Oklahoma City, OK 73112, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) | | Title | Anti-P-selectin-antistoffer og fremgangsmåder til anvendelse af disse til behandling af inflammatoriske sygdomme | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2021 00009 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
